In a single principal study, PecFent was demonstrated for being more effective than placebo (a dummy cure) at treating breakthrough cancer ache in 83 adults who have been currently being handled with opioids. The principle measure of usefulness was the change within the severity of suffering measured because of the individuals ranking their ache on